These positive results reassert the strong demand for ResMed product offerings, in particular AirSense 10 and the expanding AirSense 11 platforms. Gross margins improved by 300bps to 58.6% ...
ResMed Inc.’s RMD growth in the second quarter of fiscal 2025 can be attributed to the robust performance of its Mask business. Its Device sales continue to drive overall revenue growth. The company’s ...
CEO Michael Farrell reported 10% global revenue growth, driven by demand across the sleep health, breathing health, and residential care software portfolios. Device sales, including AirSense 10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results